Abstract
The etiology of surgical site infection (SSI) is multifactorial, with efforts to combat it employing "bundled" initiatives. Preoperative antiseptic wash was classified by the Centers for Disease Control and Prevention as a Category IB strongly recommended and accepted practice. Its inclusion, in a best-practice bundle, may contribute to reduction in SSIs. We describe our quality improvement initiative to increase adherence to this critical bundle element.
Copyright © 2019 Elsevier Inc. All rights reserved.
MeSH terms
-
Anti-Infective Agents, Local / adverse effects
-
Anti-Infective Agents, Local / therapeutic use*
-
Baths / adverse effects
-
Baths / standards*
-
Chlorhexidine / adverse effects
-
Chlorhexidine / analogs & derivatives*
-
Chlorhexidine / therapeutic use
-
Humans
-
Hygiene*
-
Inpatients*
-
Intraoperative Care / adverse effects
-
Intraoperative Care / standards*
-
Patient Care Bundles / standards*
-
Patient Compliance
-
Quality Improvement / standards*
-
Quality Indicators, Health Care / standards*
-
Surgical Wound Infection / prevention & control*
-
Time Factors
-
Treatment Outcome
-
Vascular Surgical Procedures / adverse effects
-
Vascular Surgical Procedures / standards*
Substances
-
Anti-Infective Agents, Local
-
chlorhexidine gluconate
-
Chlorhexidine